Search Within

Shakeel Modak

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (9)
Groups
  1. GSK Faculty (21)
  2. Human Oncology and Pathogenesis Program (21)
  3. Neuroblastoma Service (21)
  4. Pediatrics, Department of (21)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (20)
  6. Center for Hematologic Malignancies (19)

More Groups

People
  1. Nai-Kong Cheung (13)
  2. Brian Kushner (9)
  3. Stephen Roberts (9)
  4. Neerav Shukla (8)
  5. Emily Slotkin (7)
  6. Marc Ladanyi (7)

More People

Years
  1. 2023 (2)
  2. 2022 (2)
  3. 2021 (2)
  4. 2020 (2)
  5. 2018 (4)
  6. 2016 (1)

More Years

Publications
  1. Pediatric Blood and Cancer (5)
  2. Cancer Research (2)
  3. Clinical Cancer Research (2)
  4. Journal of Clinical Oncology (2)
  5. Cell (1)
  6. Future Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (5)
  2. Wiley Periodicals, Inc (5)
  3. American Society of Clinical Oncology (2)
  4. Nature Publishing Group (2)
  5. American Society for Clinical Investigation (1)
  6. Cell Press (1)

More Publishers

Results (21)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study
    Journal Article

    Modak, S.; Le Luduec, J. B.; Cheung, I. Y.; Goldman, D. A.; Ostrovnaya, I.; Doubrovina, E.; Basu, E.; Kushner, B. H.; Kramer, K.; Roberts, S. S.; more...
    OncoImmunology (2018)

    Fulltext@MSK | Save
  • Noninvasive molecular profiling by circulating cell-free DNA in pediatric solid tumors
    Meeting Abstract

    Kothari, P.; Slotkin, E.; Yang, J.; Stewart, C.; Gedvilaite, E.; Berger, M.; Ladanyi, M.; Shukla, N.; Modak, S.; Tsui, D.
    Pediatric Blood and Cancer (2018)

    Fulltext@MSK | Save
  • Germline mutations in cancer predisposition genes in a subset of pediatric oncology patients undergoing targeted solid tumor sequencing using matched normal DNA
    Meeting Abstract

    Walsh, M.; Shukla, N.; Joseph, V.; Kentsis, A.; Curran, K.; Kobos, R.; Arnold, A.; Harlan, M.; Kennedy, J.; Schrader, K.; more...
    Pediatric Blood and Cancer (2016)

    Fulltext@MSK | Save
  • Desmoplastic small round cell tumor 20 years after its discovery
    Journal Article

    Mora, J.; Modak, S.; Cheung, N. K.; Meyers, P.; de Alava, E.; Kushner, B.; Magnan, H.; Tirado, O. M.; Laquaglia, M.; Ladanyi, M.; more...
    Future Oncology (2015)

    Fulltext@MSK | Save
  • Predictors of overall survival in patients diagnosed with desmoplastic small round cell tumor (DSRCT)
    Meeting Abstract

    Shoushtari, A. N.; Qin, L. X.; Kuk, D.; Magnan, H. D.; Modak, S.; Wolden, S. L.; Cho, E. J.; Pallos, V.; Grubman, O.; Viny, A. D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Haploidentical natural killer cells plus monoclonal antibody 3F8 for resistant high-risk neuroblastoma: Preliminary results of an ongoing phase I study
    Meeting Abstract

    Modak, S.; Cheung, N. K. V.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S.; Gallagher, M.; Hsu, K.
    Journal of Immunotherapy (2012)

    Fulltext@MSK | Save
  • Haploidentical natural killer cells plus monoclonal antibody 3F8 for resistant high-risk neuroblastoma: Preliminary results of an ongoing phase I study
    Meeting Abstract

    Modak, S.; Cheung, N. K. V.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S. S.; Gallagher, M.; Hsu, K.
    Pediatric Blood and Cancer (2012)

    Fulltext@MSK | Save
  • Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment
    Journal Article

    Tarek, N.; Luduec, J. B. L.; Gallagher, M. M.; Zheng, J.; Venstrom, J. M.; Chamberlain, E.; Modak, S.; Heller, G.; Dupont, B.; Cheung, N. K. V.; more...
    Journal of Clinical Investigation (2012)

    Fulltext@MSK | Save
  • KIR/HLA genotypes predictive of missing KIR ligands are associated with improved outcome in patients with high-risk neuroblastoma treated with anti-GD2 monoclonal antibody therapy
    Meeting Abstract

    Gallagher, M.; Tarek, N.; Zheng, J. T.; Venstrom, J. M.; Cheung, I. Y.; Modak, S.; Dupont, B.; Cheung, N. K. V.; Hsu, K. C.
    Pediatric Blood and Cancer (2011)

    Fulltext@MSK | Save
  • NK cell killer Ig-like receptor (KIR) genotype as a novel biomarker for neuroblastoma patients receiving anti-GD2 monoclonal antibody 3F8
    Meeting Abstract

    Venstrom, J. M.; Zheng, J.; Kushner, B. H.; Modak, S.; Danis, K. E.; Cheung, I. Y.; Dupont, B.; Cheung, N. K.; Hsu, K. C.
    Cancer Research (2010)

    Fulltext@MSK | Save